Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
optical imaging (Leung Research Group) The Leung Research Group (https://sites.google.com/view/LeungGroup) in the Department of Intelligent Systems Engineering at the Luddy School of Informatics, Computing
-
Ware, MD, Phd (https://medicine.iu.edu/faculty/22816/ware-stephanie) is the Chair of the Department of Medical and Molecular Genetics as well as the program leader of the Cardiovascular Genetics Program
-
management, and data analysis. Additional opportunities may include work on the Capone Lab’s other domestic and international projects. About Us Dr. Drew Capone’s research group (https
-
Center (IUSCCC; https://cancer.iu.edu/index.html) and the Director of Graduate Studies for the Cell and Molecular Cancer Biology (CMCB) PhD program (https://medicine.iu.edu/boomington/graduate-programs
-
interdisciplinary research team at Indiana University, Bloomington. The successful candidate will contribute to cutting-edge research on the development of open- and closed-shell organic semiconducting materials
-
experimental systems — from ecosystems to microbiology and developmental biology, from evolution to cell biology, from molecular biology to systems biology, bioinformatics, and genomics. It is always an exciting
-
the areas of job performance, professional development/research support and service. Standards are outlined in the IUI Promotion & Tenure Guidelines: https://academicaffairs.indianapolis.iu.edu/Faculty
-
Library and the IU Libraries system. This is a tenure-track position with requirements for ongoing professional development and service. Responsibilities Reporting to the Head, Cataloging & Description
-
– from ecosystems to microbiology and developmental biology, from evolution to cell biology, from molecular biology to systems biology, bioinformatics, and genomics. It is always an exciting time for
-
University School of Medicine. The candidate will work on funded projects with a focus on translational cancer immunology. The recruit will be joining projects in drug development targeting the KEAP-NRF2 and